Sale!

Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test

1,060 د.إ

-10%

The Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test is a specialized diagnostic tool used to detect the presence of antibodies against aquaporin-4 (AQP4) in the blood. These antibodies are a hallmark of Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare autoimmune disorder that primarily affects the optic nerves and spinal cord, leading to vision loss, muscle weakness, and paralysis. Early and accurate detection of these antibodies is crucial for the diagnosis and management of NMOSD, as it guides treatment decisions and helps predict disease course.

Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic solutions, the test offers a reliable means of diagnosing NMOSD. The cost of the test is set at 1060 AED, reflecting the sophisticated nature of the testing process and the specialized expertise required to interpret the results. By providing access to this test, DNA Labs UAE plays a critical role in the timely and accurate diagnosis of Neuromyelitis Optica, thereby facilitating early intervention and improved outcomes for patients affected by this challenging condition.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

Anti-NMO NEUROMYELITIS OPTICA ANTIBODY AQUAPORIN 4 Test

Test Name: Anti-NMO NEUROMYELITIS OPTICA ANTIBODY AQUAPORIN 4 Test

Components: Price 1060.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST OR 1 mL (0.5 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen.

Report Delivery: Sample Tue / Fri by 9 am; Report Same day

Method: Immunofluorescence Assay

Test type: Disorders of Nervous System

Doctor: Neurologist

Test Department: IMMUNOPATHOLOGY

Pre Test Information: Test Details

The Anti-NMO (Neuromyelitis Optica) Antibody / Aquaporin 4 Test is a laboratory test used to diagnose neuromyelitis optica (NMO), also known as Devic’s disease. NMO is an autoimmune disorder that primarily affects the optic nerves and spinal cord. The test detects the presence of antibodies against aquaporin 4 (AQP4), a protein found in the central nervous system, including the optic nerves and spinal cord. These antibodies are believed to play a role in the development of NMO by attacking and damaging the myelin sheath, which is the protective covering of nerve fibers.

The test involves taking a blood sample from the patient and analyzing it in the laboratory. If the test results show the presence of anti-AQP4 antibodies, it indicates a high likelihood of NMO. However, it is important to note that not all individuals with NMO will test positive for these antibodies, and some individuals without NMO may still have these antibodies present.

The Anti-NMO Antibody / AQP4 Test is typically ordered by a healthcare provider if NMO is suspected based on the individual’s symptoms, such as optic neuritis (inflammation of the optic nerve) and transverse myelitis (inflammation of the spinal cord). It can help differentiate NMO from other similar conditions, such as multiple sclerosis.

Early diagnosis of NMO is crucial for initiating appropriate treatment and preventing further damage to the central nervous system. Treatment for NMO usually involves immunosuppressive medications to reduce inflammation and prevent relapses.

Test Name Anti-NMO NEUROMYELITIS OPTICA ANTIBODY AQUAPORIN 4 Test
Components
Price 1060.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST OR 1 mL (0.5 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen.
Report Delivery SampleTue / Fri by 9 am; Report Same day
Method Immunofluorescence Assay
Test type Disorders of Nervous System
Doctor Neurologist
Test Department: IMMUNOPATHOLOGY
Pre Test Information
Test Details

The Anti-NMO (Neuromyelitis Optica) Antibody / Aquaporin 4 Test is a laboratory test used to diagnose neuromyelitis optica (NMO), also known as Devic’s disease. NMO is an autoimmune disorder that primarily affects the optic nerves and spinal cord.

The test detects the presence of antibodies against aquaporin 4 (AQP4), a protein found in the central nervous system, including the optic nerves and spinal cord. These antibodies are believed to play a role in the development of NMO by attacking and damaging the myelin sheath, which is the protective covering of nerve fibers.

The test involves taking a blood sample from the patient and analyzing it in the laboratory. If the test results show the presence of anti-AQP4 antibodies, it indicates a high likelihood of NMO. However, it is important to note that not all individuals with NMO will test positive for these antibodies, and some individuals without NMO may still have these antibodies present.

The Anti-NMO Antibody / AQP4 Test is typically ordered by a healthcare provider if NMO is suspected based on the individual’s symptoms, such as optic neuritis (inflammation of the optic nerve) and transverse myelitis (inflammation of the spinal cord). It can help differentiate NMO from other similar conditions, such as multiple sclerosis.

Early diagnosis of NMO is crucial for initiating appropriate treatment and preventing further damage to the central nervous system. Treatment for NMO usually involves immunosuppressive medications to reduce inflammation and prevent relapses.